11Q13 AMPLIFICATION IN LOCAL RECURRENCE OF HUMAN PRIMARY BREAST-CANCER

Citation
Mh. Champeme et al., 11Q13 AMPLIFICATION IN LOCAL RECURRENCE OF HUMAN PRIMARY BREAST-CANCER, Genes, chromosomes & cancer, 12(2), 1995, pp. 128-133
Citations number
29
Categorie Soggetti
Oncology,"Genetics & Heredity
Journal title
ISSN journal
10452257
Volume
12
Issue
2
Year of publication
1995
Pages
128 - 133
Database
ISI
SICI code
1045-2257(1995)12:2<128:1AILRO>2.0.ZU;2-Q
Abstract
Breast cancer can relapse both locally and at distant metastatic sites . The mechanism of local recurrence is unknown, but seems to be due no t only to the number of residual cancer cells (inadequate irradiation or surgery), but also to their generically determined malignant potent ial. To identify genetic alterations associated with local recurrence risk in breast carcinoma, we analyzed 28 local recurrences and 173 pri mary breast tumors for the ten most frequently altered genetic regions in breast carcinomas, i.e., loss of heterozygosity on chromosomal arm s 1p, 3p, 7q, 11p, 17p, 17q, and 18q, and amplification of the MYC and ERBB2 protooncogenes and of genes in 11q13. Only INT2/FGF3 and CCNDI, located in 11q13, were more frequently amplified in local recurrences than in primary tumors (39% vs. 17%; P < 0.01). Moreover, recurrence- free survival was shorter when the 11q13 region was amplified. These r esults suggest that one or more genes located in 11q13 play an importa nt role in local relapses of breast cancer. (C) 1995 Wiley-Liss, Inc.